ストックスクリーナーアプリを入手
0.4383
8.11%
-0.0387
前日終値:
$0.477
開ける：
$0.4627
24時間の取引高:
145.40K
Relative Volume:
0.99
時価総額：
$27.52M
収益：
$37.20M
当期純損益:
$-11.85M
株価収益率:
-2.2972
EPS:
-0.1908
ネットキャッシュフロー:
$-10.59M
1週間 パフォーマンス:
+12.93%
1か月 パフォーマンス:
-8.50%
6か月 パフォーマンス:
-32.04%
1年 パフォーマンス:
-62.22%
1日の値動き範囲:
$0.4383
$0.4999
1週間の範囲:
$0.3814
$0.6048
52週間の値動き範囲:
$0.3695
$1.39
Cytosorbents Corp Stock (CTSO) Company Profile
Compare CTSO vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CTSO
Cytosorbents Corp
|
0.4383 | 27.52M | 37.20M | -11.85M | -10.59M | -0.1908 |
ABT
Abbott Laboratories
|
88.41 | 153.99B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.80 | 118.00B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
79.34 | 101.86B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
45.29 | 67.32B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.36 | 50.30B | 6.30B | 1.07B | 1.09B | 1.8406 |
Cytosorbents Corp Stock (CTSO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-09-07 | 開始されました | B. Riley Securities | Buy |
| 2021-10-14 | 再開されました | B. Riley Securities | Buy |
| 2020-09-17 | 開始されました | Jefferies | Buy |
| 2020-09-01 | 開始されました | SVB Leerink | Outperform |
| 2017-08-08 | 繰り返されました | Maxim Group | Buy |
| 2016-10-26 | 開始されました | Aegis Capital | Buy |
| 2016-05-24 | 開始されました | Maxim Group | Buy |
| 2015-10-29 | アップグレード | WBB Securities | Speculative Buy → Buy |
| 2015-05-12 | 繰り返されました | MLV & Co | Buy |
| 2015-04-01 | 繰り返されました | MLV & Co | Buy |
| 2015-03-05 | 開始されました | MLV & Co | Buy |
| 2015-02-25 | 開始されました | WBB Securities | Speculative Buy |
| 2015-01-27 | 繰り返されました | H.C. Wainwright | Buy |
すべてを表示
Cytosorbents Corp (CTSO) 最新ニュース
CytoSorbents to Present at the Life Sciences Forum on June 24, 2026 and Meet Virtually with Investors on June 30, 2026 - Yahoo Finance
Cytosorbents Corp (CTSO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Cytosorbents Corp (CTSO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Cytosorbents Corp (CTSO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Cytosorbents Corp (CTSO) Institutional Confidence - TradingKey
Cytosorbents Corp (CTSO) Valuation: PE, PB & Fair Value Analysis - TradingKey
Cytosorbents Corp (CTSO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Cytosorbents Corp (CTSO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Cytosorbents Corp (CTSO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Cytosorbents Corp (CTSO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Cytosorbents CFO Peter Mariani buys $44,000 in stock - Investing.com UK
Cytosorbents CFO Peter Mariani buys $44,000 in stock By Investing.com - Investing.com India
Cytosorbents (CTSO) CFO Peter Mariani buys 100,000 shares in open market - Stock Titan
Cytosorbents CEO Phillip Chan buys $104,897 in company stock - Investing.com
CTSO | Cytosorbents Corp. FinancialsIncome Statement - Quiver Quantitative
Cytosorbents (CTSO) CEO boosts stake with 261,469-share open-market buy - Stock Titan
Cytosorbents Corporation (NASDAQ:CTSO): Is Breakeven Near? - simplywall.st
CytoSorbents (NASDAQ: CTSO) asks shareholders to OK 1-for-5–1-for-20 reverse split - Stock Titan
CytoSorbents Corp stock (US23283M1018): Q1 miss keeps focus on growth and cash runway - AD HOC NEWS
CTSO Technical Analysis & Stock Price Forecast - Intellectia AI
CytoSorbents Corp stock (US23283M1018): analyst sentiment and low share price keep focus on Nasdaq-l - AD HOC NEWS
CytoSorbents Corp stock (US23283M1018): Nasdaq price action and valuation metrics in focus - AD HOC NEWS
Cytosorbents Earnings Call Balances Progress and Pressure - The Globe and Mail
Why Cytosorbents (CTSO) Just Dropped -1.78% — What to Watch 2026-05-20Expert Momentum Signals - Newser
Earnings call transcript: CytoSorbents Q1 2026 misses forecasts, stock falls - Investing.com
Cytosorbents (CTSO) Q1 2026 Disappoints — EPS $-0.08 Below $-0.06 ViewsDividend Growth Analysis - Newser
Cytosorbents Corporation (NASDAQ:CTSO) Q1 2026 Earnings Call Transcript - Insider Monkey
Cytosorbents Earnings Call Balances Progress And Pressure - The Globe and Mail
CytoSorbents Corp (CTSO) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic Growth - GuruFocus
Is CytoSorbents (CTSO) a Value Trap Despite 39.9% Undervaluation - GuruFocus
CytoSorbents (CTSO) Reports Q1 Revenue Growth - GuruFocus
Transcript: CytoSorbents Q1 2026 Earnings Conference Call - Yahoo Finance
Cytosorbents Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Cytosorbents Corp 1Q 2026: Revenue $8.86M, EPS ($0.08) — 10-Q Summary - TradingView
CYTOSORBENTS ($CTSO) Releases Q1 2026 Earnings - Quiver Quantitative
CytoSorbents (CTSO) posts wider Q1 2026 loss and flags going-concern risk - Stock Titan
CytoSorbents (NASDAQ: CTSO) details DrugSorb-ATR FDA path and Q1 2026 results - Stock Titan
CytoSorbents: Q1 Earnings Snapshot - marketscreener.com
CytoSorbents Reports First Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update - Fidelity
CytoSorbents Q1 earnings preview - MSN
Cytosorbents Corp expected to post a loss of 5 cents a shareEarnings Preview - TradingView
CytoSorbents Announces HotSwap™ Launch, Renewed Aferetica Partnership, and New Clinical Evidence at ISICEM 2026 - Quantisnow
CTSO (Cytosorbents) revenue climbs 4.1% to $37.1M in Q1 but loss widens, shares flat.Earnings Yield Analysis - Newser
CytoSorbents to Report First Quarter 2026 Financial Results and Recent Business Highlights - BioSpace
CTSO Cytosorbents shares climb 6 percent today despite reporting a wider than expected Q4 2025 per share loss.Mid-Term Outlook - thelegaladvocate.com
CytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights - Aktiellt
CTSO Analyst Rating Update: HC Wainwright Lowers Price Target | - GuruFocus
Executive Compensation, Stock Options, and Corporate Governance Disclosure - Minichart
Governance, pay and ownership detailed in CytoSorbents (NASDAQ: CTSO) 10-K/A - Stock Titan
CytoSorbents Receives Nasdaq Extension to Regain Compliance - The Globe and Mail
CytoSorbents implemented workforce and cost reduction program - TipRanks
Cytosorbents Corp (CTSO) 財務データ
収益
当期純利益
現金流量
EPS
0.93%
大文字化:
|
ボリューム (24 時間):